PainReform Provides Business Update for the Second Quarter of 2023
Provided By GlobeNewswire
Last update: Aug 10, 2023
TEL AVIV, Israel, Aug. 10, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the second quarter ended June 30, 2023.
Read more at globenewswire.com1.86
-0.08 (-4.12%)
Find more stocks in the Stock Screener
PRFX Latest News and Analysis
4 days ago - ChartmillGet insights into the top gainers and losers of Wednesday's after-hours session.Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
